Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1997 1
2002 1
2010 1
2011 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective study.
van Gorkom T, Kremer K, Voet W, Notermans DW, Vlaminckx BJM, Sankatsing SUC, Thijsen SFT. van Gorkom T, et al. Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2137-2146. doi: 10.1007/s10096-017-3037-1. Epub 2017 Jul 26. Eur J Clin Microbiol Infect Dis. 2017. PMID: 28748396 Free PMC article.
The diagnosis of Lyme borreliosis is challenging because of the often non-specific symptoms and persisting antibodies after infection. We investigated the diagnostic characteristics of two enzyme-linked immunosorbent assays (ELISAs) and an immun …
The diagnosis of Lyme borreliosis is challenging because of the often non-specific symptoms and persisting an
Identification of species-specific, non-cross-reactive proteins of Borrelia burgdorferi.
Sayahtaheri-Altaie S, Meier FA, Dalton HP. Sayahtaheri-Altaie S, et al. Diagn Microbiol Infect Dis. 1993 Jan;16(1):43-51. doi: 10.1016/0732-8893(93)90129-u. Diagn Microbiol Infect Dis. 1993. PMID: 8425377
The low sensitivity is a result of high (> or = 1:100) dilutions used for patient sera during testing to eliminate non-specific cross-reactivity. The present study was conducted to identify species-specific non-cross-reactive protein( …
The low sensitivity is a result of high (> or = 1:100) dilutions used for patient sera during testing to eliminate non
Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
Panelius J, Lahdenne P, Heikkilä T, Peltomaa M, Oksi J, Seppälä I. Panelius J, et al. J Med Microbiol. 2002 Sep;51(9):731-739. doi: 10.1099/0022-1317-51-9-731. J Med Microbiol. 2002. PMID: 12358063
Genes for the outer-surface protein C (OspC) from three north European human isolates of Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii were cloned and sequenced. ...Of the patients, 53% (8/15) with neuroborreliosis (NB) and 53% (8/15) w …
Genes for the outer-surface protein C (OspC) from three north European human isolates of Borrelia burgdorferi sensu str …
The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic.
Djukic M, Schmidt-Samoa C, Nau R, von Steinbüchel N, Eiffert H, Schmidt H. Djukic M, et al. Eur J Neurol. 2011 Apr;18(4):547-55. doi: 10.1111/j.1468-1331.2010.03229.x. Epub 2010 Oct 27. Eur J Neurol. 2011. PMID: 20977545
BACKGROUND AND PURPOSE: Studies addressing the diagnostic relevance of anti-Borrelia burgdorferi (BB) serum antibodies in patients with non-specific symptoms and suspected chronic Lyme neuroborreliosis (LNB) are scarce. ...All p
BACKGROUND AND PURPOSE: Studies addressing the diagnostic relevance of anti-Borrelia burgdorferi (BB) serum antibodies
Clinical value of specific intrathecal production of antibodies.
Treib J, Woessner R, Dobler G, Fernandez A, Holzer G, Schimrigk K. Treib J, et al. Acta Virol. 1997 Feb;41(1):27-30. Acta Virol. 1997. PMID: 9199711
The time period between the beginning of the symptoms and the time of the CSF examination ranged from one day to six weeks. Seventy-seven patients showed a production of intrathecal antibodies against Borrelia burgdorferi. Three of these pati
The time period between the beginning of the symptoms and the time of the CSF examination ranged from one day to six weeks. Seventy-s …
[Lyme disease in Chile. Prevalence study in selected groups].
Neira O, Cerda C, Alvarado MA, Palma S, Abumohor P, Wainstein E, Guzmán L, Juliet C, Pérez C, Raggio X, Rojas I, Honorato H, Alcaíno H, Fredes F. Neira O, et al. Rev Med Chil. 1996 May;124(5):537-44. Rev Med Chil. 1996. PMID: 9035504 Spanish.
PATIENTS AND METHODS: One hundred eighteen patients with signs or symptoms suggestive of Lyme disease were studied. Antibodies against Borrelia burgdorferi were measured using ELISA and indirect immunofluorescence screening tests.
PATIENTS AND METHODS: One hundred eighteen patients with signs or symptoms suggestive of Lyme disease were studied.
Feedback